Following the success of its first two investment funds, KIKK Capital is launching a third fund: KIKK Capital II. The new fund targets Dutch startups and scale-ups developing a hardware product and those biotech companies developing platform technology that have achieved initial commercial successes.
Over the next few years, KIKK Capital II will invest €20 million in 10 to 15 enterprises. The fund has been made possible by 20 private investors and an investment from the RVO Seed Capital scheme. In addition to capital, the investors and fund management will make available their knowledge, expertise, and networks gained from prominent positions in the international business sphere to the invested companies.
Since the inception of the first fund, KIKK Capital has invested in 18 Dutch enterprises, including MIMETAS, Toxys, LIQAL, a DFS company, SystematIC Design B.V., and Tracefy.
